Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Isabel Tena"'
Autor:
Matilde Sánchez-Conde, Pilar Vizcarra, José Manuel Pérez-García, María Gion, María Pilar Martialay, Javier Taboada, Alberto Alonso-Fernández, Miguel Sampayo-Cordero, Andrea Malfettone, Isabel Tena, Sergio De La Torre, Antonio Llombart-Cussac, Javier Cortés
Publikováno v:
International Journal of Infectious Diseases, Vol 123, Iss , Pp 97-103 (2022)
Objectives: Severe COVID-19 is associated with immune dysregulation and hyperinflammation (lymphocyte exhaustion and elevated interleukin 6. Pembrolizumab (P; immune-activating anti-programmed cell death-1 antibody) plus tocilizumab (TCZ; anti- inter
Externí odkaz:
https://doaj.org/article/03300a66cee940b7bc9b769d46d85504
Autor:
Marta Ramírez-Calvo, Zaida García-Casado, Antonio Fernández-Serra, Inmaculada de Juan, Sarai Palanca, Silvestre Oltra, José Luis Soto, Adela Castillejo, Víctor M Barbera, Ma José Juan-Fita, Ángel Segura, Isabel Chirivella, Ana Beatriz Sánchez, Isabel Tena, Carolina Chaparro, Dolores Salas, José Antonio López-Guerrero
Publikováno v:
Hereditary Cancer in Clinical Practice, Vol 17, Iss 1, Pp 1-7 (2019)
Abstract Background Approximately 5 to 10% of all cancers are caused by inherited germline mutations, many of which are associated with different Hereditary Cancer Syndromes (HCS). In the context of the Program of Hereditary Cancer of the Valencia Co
Externí odkaz:
https://doaj.org/article/59943a328e9e4837b9229c49cbe8b25d
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
Neuroendocrine tumors overexpress somatostatin receptors, which serve as important and unique therapeutic targets for well-differentiated advanced disease. This overexpression is a well-established finding in gastroenteropancreatic neuroendocrine tum
Externí odkaz:
https://doaj.org/article/f2686e961f0a4b048cbf4c035809dde0
Autor:
Isabel Tena, José Luis Ponce, Marcos Tajahuerce, José Luis Vercher-Conejero, Manuel Cifrián, Katherine I. Wolf, Marcela Miret, Maribel del Olmo, Rosa Reboll, Antonio Conde, Francisca Moreno, Julia Balaguer, Adela Cañete, Rosana Palasí, Alfredo Marco, Juan Francisco Merino Torres, Carlos Ferrer, Alfredo Sánchez, José Luis Soto, Antonio Llombart, Karel Pacak
Publikováno v:
Journal of Clinical and Translational Endocrinology Case Reports, Vol 7, Iss , Pp 8-13 (2018)
Objective: Pheochromocytomas (PHEOs) and paragangliomas (PGLs) arise from adrenal extra-adrenal paraganglia. They often secrete catecholamine and approximately 1/3 are hereditary. Almost 50% of metastatic PGLs are caused by mutations in the succinate
Externí odkaz:
https://doaj.org/article/7ce76c315cda4ae6a1095fde28090db7
Autor:
Abhishek Jha, Kristine de Luna, Charlene Ann Balili, Corina Millo, Cecilia Angela Paraiso, Alexander Ling, Melissa K. Gonzales, Bruna Viana, Rami Alrezk, Karen T. Adams, Isabel Tena, Alice Chen, Jiri Neuzil, Margarita Raygada, Electron Kebebew, David Taieb, M. Sue O'Dorisio, Thomas O'Dorisio, Ali Cahid Civelek, Constantine A. Stratakis, Leilani Mercado-Asis, Karel Pacak
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Background: Pheochromocytoma and paraganglioma (PHEO/PGL) are rare neuroendocrine tumors which may cause potentially life-threatening complications, with about a third of cases found to harbor specific gene mutations. Thus, early diagnosis, treatment
Externí odkaz:
https://doaj.org/article/3cb9302e5ead419f910f1ecd3cb52a7d
Publikováno v:
Frontiers in Endocrinology, Vol 9 (2018)
Pheochromocytomas and paragangliomas (PCCs/PGLs) are rare commonly benign neuroendocrine tumors that share pathology features and clinical behavior in many cases. While PCCs are chromaffin-derived tumors that arise within the adrenal medulla, PGLs ar
Externí odkaz:
https://doaj.org/article/36be7cb2b5c54b9f8da1750a02908d13
Autor:
Isabel Tena, Garima Gupta, Marcos Tajahuerce, Marta Benavent, Manuel Cifrián, Alejandro Falcon, María Fonfria, Maribel del Olmo, Rosa Reboll, Antonio Conde, Francisca Moreno, Julia Balaguer, Adela Cañete, Rosana Palasí, Pilar Bello, Alfredo Marco, José Luis Ponce, Juan Francisco Merino, Antonio Llombart, Alfredo Sanchez, Karel Pacak
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 12 (2018)
Metastatic pheochromocytoma and paraganglioma (mPHEO/PGL) are frequently associated with succinate dehydrogenase B ( SDHB ) mutations. Cyclophosphamide-dacarbazine-vincristine (CVD) regimen is recommended as standard chemotherapy for advanced mPHEO/P
Externí odkaz:
https://doaj.org/article/5c24168471b54ef793ab1cca8105515d
Autor:
Matilde Sánchez-Conde, Pilar Vizcarra, José Manuel Pérez-García, María Gion, María Pilar Martialay, Javier Taboada, Alberto Alonso-Fernández, Miguel Sampayo-Cordero, Andrea Malfettone, Isabel Tena, Sergio De La Torre, Antonio Llombart, Javier Cortes
IntroductionSevere coronavirus disease 2019 (COVID-19) is associated with immune dysregulation and hyperinflammation (lymphocyte exhaustion and elevated IL-6). Pembrolizumab (P; immune-activating anti-PD-1 antibody) plus tocilizumab (TCZ; anti-IL6 re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0858275421f82749065a04bec76ac576
https://doi.org/10.21203/rs.3.rs-1386212/v1
https://doi.org/10.21203/rs.3.rs-1386212/v1
Autor:
Inmaculada de Juan Jiménez, Eduardo Martinez-Dueńas, Maria Fonfria, Ana Beatriz Sánchez-Heras, Isabel Chirivella, Paula Richart-Aznar, Ángel Segura, Isabel Tena
Publikováno v:
Journal of Personalized Medicine
Volume 11
Issue 6
Journal of Personalized Medicine, Vol 11, Iss 548, p 548 (2021)
Volume 11
Issue 6
Journal of Personalized Medicine, Vol 11, Iss 548, p 548 (2021)
(1) Background: Over the last decade, genetic counseling clinics have moved from single-gene sequencing to multigene panel sequencing. Multiple genes related to a moderate risk of breast cancer (BC) have emerged, although many questions remain regard
Publikováno v:
Frontiers in Endocrinology
Frontiers in Endocrinology, Frontiers, 2021, 12, ⟨10.3389/fendo.2021.625312⟩
Frontiers in Endocrinology, Vol 12 (2021)
Frontiers in Endocrinology, 2021, 12, ⟨10.3389/fendo.2021.625312⟩
Frontiers in Endocrinology, Frontiers, 2021, 12, ⟨10.3389/fendo.2021.625312⟩
Frontiers in Endocrinology, Vol 12 (2021)
Frontiers in Endocrinology, 2021, 12, ⟨10.3389/fendo.2021.625312⟩
Neuroendocrine tumors overexpress somatostatin receptors, which serve as important and unique therapeutic targets for well-differentiated advanced disease. This overexpression is a well-established finding in gastroenteropancreatic neuroendocrine tum